ALLR Allarity Therapeutics Inc.: מכפיל שווי פעילות להכנסות

The key growth driver for Allarity Therapeutics (ALLR) is the development of personalized drugs via the DRP system, which shapes the business value-to-revenue dynamics. The value of 36485.71 reflects this status. Revenues are projected to stem from insurance payouts for the treatment of complex pathologies. Furthermore, the business relies on complete independence from economic cycles and macroeconomic shocks.
ALLR (allarity.com): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This indicator determines the enterprise value of the business, including debt and excluding cash, relative to sales volume, allowing for an assessment of revenue generation efficiency without the influence of debt load. By analyzing the business valuation via EV/Sales, an investor will see how inflated the expectations for stenoparib are against a backdrop of critical liquidity shortages and the acute need for working capital at Allarity Therapeutics (ALLR).